News US is planning $500m project on 'universal vaccines;' WSJ The US will spend $500m to develop universal vaccines against multiple virus variants, while planned changes to testing rules are raising concerns.
News France probes side effects with Valneva's chikungunya jab France's national public health agency has halted dosing of Valneva's chikungunya vaccine in older people while it investigates a safety signal.
News Measles claims another life in US – and RFK Jr lauds vaccine A second child has died of measles in the midst of an outbreak of cases that has now affected around 642 people in the US since January.
News GSK ends decades-long hiatus in oral antibiotics for UTIs The FDA has approved GSK's Blujepa, the first new-mechanism oral antibiotic for uncomplicated UTIs in nearly 30 years, after a priority review.
News MIT team develops 'years-long' drug delivery tech Researchers in the US have devised a new depot system that could provide months or even years of delivery from a single subcutaneous injection.
News Concern as measles cases doubled in Europe last year A sharp rise in measles cases in 2024 in Europe has led to widespread calls for a concerted effort to ramp up vaccination rates.
R&D Modelling biologics: Challenges and opportunities, with Dr D... From AAPS 2025, an interview with Dr Dhaval Shah, professor of pharmaceutical sciences at the University of Buffalo and former Pfizer researcher.
Market Access Sponsored Bridging research and clinical guidelines – interactive stra... Medical affairs is evolving. Understanding how to harness real-world data and digital insights is essential.